Trial Profile
Effect of dutasteride on intraprostatic dihydrotestosterone (DHT) levels
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 16 Oct 2006 Status change
- 22 Dec 2005 New trial record.